Indaptus Therapeutics raised $5.7 million through the sale of convertible promissory notes and warrants for R&D purposes. Indaptus Therapeutics, Inc., a clinical stage biotech company, announced the ...
Repayment of Convertible Promissory Note removes January 2026 maturity, eliminates potential equity overhang and strengthens balance sheet Tigo Energy, Inc. (NASDAQ: TYGO) ("Tigo"), a leading provider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results